Intracellular leptin-signaling pathways in hypothalamic neurons: The emerging role of phosphatidylinositol-3 kinase-phosphodiesterase-3B-cAMP pathway

Neuroendocrinology

Volumn 93, Issue 4, 2011, Pages 201-210

  Sahu, Abhiram ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

cAMP; Diet induced obesity; Hypothalamus; Leptin; Leptin resistance; Phosphodiesterase 3B; PI3K; STAT3

Indexed keywords

CILOSTAMIDE; CYCLIC AMP; INSULIN RECEPTOR SUBSTRATE 1; JANUS KINASE 2; LEPTIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y; NEUROTENSIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IIIB; PROOPIOMELANOCORTIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BODY WEIGHT; BRAIN NERVE CELL; DIETARY INTAKE; ENERGY BALANCE; HOMEOSTASIS; HORMONE RESISTANCE; HORMONE SENSITIVITY; HUMAN; HYPOTHALAMUS; INTRACELLULAR SIGNALING; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; HUMANS; HYPOTHALAMUS; LEPTIN; NEURONS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 79959375716     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000326785     Document Type: Article

References (78)

1. Hervey GR: The effects of lesions in the hy-pothalamus in parabiotic rats. J Physiol 1959; 145:336-352.
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human ho-mologue. Nature 1994; 372: 425-432. (Pubitemid 24365442)
3. Friedman JM, Halaas JL: Leptin and the reg-ulation of body weight in mammals. Nature 1998; 395: 763-770. (Pubitemid 28485436)
4. Sahu A: Leptin signaling in the hypothala-mus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol 2003; 24: 225-253. (Pubitemid 38064317)
5. Yadav VK, Oury F, Suda N Liu ZW, Gao XB, Confavreux C, Klemenhagen KC, Tanaka KF, Gingrich JA, Guo XE, Tecott LH, Mann JJ, Hen R, Horvath TL, Karsenty G: A sero-tonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009; 138: 976-989.
6. Cao L, Liu X, Lin EJ, Wang C, Choi EY, Riban V, Lin B, During MJ: Environmental and genetic activation of a brain-adipocyte BDNF/ leptin axis causes cancer remission and inhi-bition. Cell 2010; 142:52-64.
7. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB: Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998; 395: 535-547. (Pubitemid 28226097)
8. Caron E, Sachot C, Prevot V, Bouret SG: Distribution of leptin-sensitive cells in the post-natal and adult mouse brain. J Comp Neurol 2010; 518: 459-476.
9. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG: Central nervous system con-trol of food intake. Nature 2000; 404:661-671. (Pubitemid 30205071)
10. Cone RD: Studies on the physiological func-tions of the melanocortin system. Endocr Rev 2006; 27:736-749. (Pubitemid 44936057)
11. Sahu A: A hypothalamic role in energy bal-ance with special emphasis on leptin. Endocrinology 2004; 145: 2613-2620. (Pubitemid 38686205)
12. Sahu A: Leptin decreases food intake in-duced by melanin-concentrating hormone, galanin and neuropeptide Y in the rat. Endocrinology 1998; 139: 4739-4742. (Pubitemid 28487794)
13. Ellacott KL, Lawrence CB, Rothwell NJ, Luckman SM: PRL-releasing peptide inter-acts with leptin to reduce food intake and body weight. Endocrinology 2002; 143:368-374. (Pubitemid 34107188)
14. Myers MG Jr, Munzberg H, Leinninger GM, Leshan RL: The geometry of leptin action in the brain: more complicated than a simple ARC. Cell Metab 2009; 9: 117-123.
15. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW: Central nervous system control of food intake and body weight. Nature 2006; 443: 289-295. (Pubitemid 44435142)
16. Leinninger GM, Jo YH, Leshan RL, Louis GW, Yang H, Barrera JG, Wilson H, Opland DM, Faouzi MA, Gong Y, Jones JC, Rhodes CJ, Chua S Jr, Diano S, Horvath TL, Seeley RJ, Becker JB, Munzberg H, Myers MG Jr: Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and sup-press feeding. Cell Metab 2009; 10:89-98.
17. Hayes MR, Skibicka KP, Leichner TM, Guar-nieri DJ, DiLeone RJ, Bence KK, Grill HJ: Endogenous leptin signaling in the caudal nu-cleus tractus solitarius and area postrema is required for energy balance regulation. Cell Metab 2010; 11:77-83.
18. Tartaglia LA: The leptin receptor. J Biol Chem 1997; 272:6093-6096. (Pubitemid 27118072)
19. Coppari R, Ichinose M, Lee CE, Pullen AE, Kenny CD, McGovern RA, Tang V, Liu SM, Ludwig T, Chua SC Jr, Lowell BB, Elmquist JK: The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 2005; 1:63-72. (Pubitemid 43960588)
20. Ring LE, Zeltser LM: Disruption of hypotha-lamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels. J Clin Invest 2010; 120: 2931-2941.
21. Zhao AZ, Huan JN, Gupta S, Pal R, Sahu A: A phosphatidylinositol 3-kinase phosphodi-esterase-3B cyclic AMP pathway in hypotha-lamic action of leptin on feeding. Nat Neuro-sci 2002; 5:727-728. (Pubitemid 34827588)
22. Myers MG, Cowley MA, Munzberg H: Mechanisms of leptin action and leptin resis-tance. Annu Rev Physiol 2008; 70:537-556.
23. Rahmouni K, Sigmund CD, Haynes WG, Mark AL: Hypothalamic ERK mediates the anorectic and thermogenic sympathetic ef-fects of leptin. Diabetes 2009; 58: 536-542.
24. Hubschle T, Thom E, Watson A, Roth J, Klaus S, Meyerhof W: Leptin-induced nucle-ar translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J Neurosci 2001; 21: 2413-2424. (Pubitemid 32240538)
25. Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, Shulman GI, Fu XY: Disruption of neural signal transducer and activator of transcription-3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 2004; 101: 4661-4666. (Pubitemid 38437467)
26. Piper ML, Unger EK, Myers MG Jr, Xu AW: Specific physiological roles for signal trans-ducer and activator of transcription-3 in leptin receptor-expressing neurons. Mol Endocrinol 2008; 22:751-759. (Pubitemid 351397800)
27. Gong L, Yao F, Hockman K, Heng HH, Mor-ton GJ, Takeda K, Akira S, Low MJ, Rubin-stein M, MacKenzie RG: Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neu-ropeptide Y neurons for normal energy ho-meostasis. Endocrinology 2008; 149:3346-3354. (Pubitemid 351919579)
28. Xu AW, Ste-Marie L, Kaelin CB, Barsh GS: Inactivation of signal transducer and activator of transcription-3 in proopiomelanocor-tin (POMC) neurons causes decreased POMC expression, mild obesity, and defects in compensatory refeeding. Endocrinology 2007; 148:72-80. (Pubitemid 46021439)
29. Mutze J, Roth J, Gerstberger R, Hubschle T: Nuclear translocation of the transcription factor STAT5 in the rat brain after systemic leptin administration. Neurosci Lett 2007; 417:286-291. (Pubitemid 46589788)
30. Lee JY, Muenzberg H, Gavrilova O, Reed JA, Berryman D, Villanueva EC, Louis GW, Leinninger GM, Bertuzzi S, Seeley RJ, Rob-inson GW, Myers MG, Hennighausen L: Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy bal-ance and leads to obesity. PLoS One 2008; 3:e1639.
31. Soderling SH, Beavo JA: Regulation of cAMP and cGMP signaling: new phosphodiester-ases and new functions. Curr Opin Cell Biol 2000; 12:174-179. (Pubitemid 30142563)
32. Bender AT, Beavo JA: Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006; 58: 488-520. (Pubitemid 44394910)
33. Gillard ER, Khan AM, Ahsanul H, Grewal RS, Mouradi B, Stanley BG: Stimulation of eating by the second messenger cAMP in the perifornical and lateral hypothalamus. Am J Physiol 1997; 273:R107-R112.
34. Akabayashi A, Zaia CT, Gabriel SM, Silva I, Cheung WK, Leibowitz SF: Intracerebroven-tricular injection of dibutyryl cyclic adeno-sine 3',5'-monophosphate increases hypo-thalamic levels of neuropeptide Y Brain Res 1994; 660:323-328. (Pubitemid 24303635)
35. Shimizu-Albergine M, Ippolito DL, Beavo JA: Downregulation of fasting-induced cAMP response element-mediated gene in-duction by leptin in neuropeptide Y neurons of the arcuate nucleus. J Neurosci 2001; 21: 1238-1246. (Pubitemid 32128768)
36. Reinhardt RR, Chin E, Zhou J, Taira M, Mu-rata T, Manganiello VC, Bondy CA: Distinc-tive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phos-phodiesterases. J Clin Invest 1995; 95:1528-1538.
37. Beavo JA, Reifsnyder, DH: Primary sequence of cyclic nucleotide phosphodiesterase iso-zymes and the design of selective inhibitors. Trends Pharmacol Sci 1990; 11:150-155. (Pubitemid 20118008)
38. Niswender KD, Gallis B, Blevins JE, Corson MA, Schwartz M W, Baskin DG: Immunocy-tochemical detection of phosphatidylinosi-tol 3-kinase activation by insulin and leptin. J Histochem Cytochem 2003; 51: 275-283. (Pubitemid 36245983)
39. Morrison CD, Morton GJ, Niswender KD, Gelling RW, Schwartz MW: Leptin inhibits hypothalamic Npy and Agrp gene expres-sion via a mechanism that requires phospha-tidylinositol 3-OH-kinase signaling. Am J Physiol Endocrinol Metab 2005; 289:E1051-E1057. (Pubitemid 43772054)
40. Sahu A, Metlakunta AR: Evidence suggest-ing phosphatidylinositol 3-kinase as an up-stream regulator of phosphodiesterase-3B-mediated leptin signaling in the hypothalamus. Program No. 380.4. 2004 Abstract Viewer/Itinerary Planner. Washington, So-ciety for Neuroscience, 2004.
41. Koshinaka K, Sahu A: Leptin signaling in the hypothalamus does not involve activation of protein kinase B/AKT in the rat hypothala-mus. Program No. 20.1. 2007 Neuroscience Meeting Planner. San Diego, Society for Neuroscience, 2007.
42. Litvin D, Sahu M, Koshinaka K, Sahu A: Evidence showing phosphodiesterase-3B co-localization in proopiomelanocortin and neuropeptide Y expressing neurons in the hypothalamus: further insight into leptin signaling. 89th Annual Meeting of the Endo-crine Society, Toronto, June 2-5, 2007, abstr P4-4.
43. Sahu A, Sahu M: Leptin receptor expressing neurons co-express phosphodiesterase-3B (PDE3B) and leptin induces STAT3 activa-tion in PDE3B neurons in the hypothalamus: potential mechanism of leptin signaling. Program No. 783.25. 2008 Neuroscience Meeting Planner. Washington, Society for Neuroscience, 2008.
44. Sahu A: A role of phosphodiesterase-3B pathway in mediating leptin action on pro-opiomelanocortin and neurotensin neurons in the hypothalamus. Neurosci Lett 2010; 479:18-21.
45. Leonard WJ, O'Shea JJ: Jaks and STATs: bio-logical implications. Annu Rev Immunol 1998; 16: 293-322.
46. Caron E, Sachot C, Prevot V, Bouret SG: Distribution of leptin-sensitive cells in the post-natal and adult mouse brain. J Comp Neurol 2010; 518: 459-476.
47. Munzburg H, Huo L, Nillni EA, Hollenberg AN, Bjorbaek C: Role of signal transducer and activator of transcription-3 in regula-tion of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology 2003; 144:2121-2131. (Pubitemid 36543352)
48. Metlakunta AS, Sahu M, Sahu A: Hypotha-lamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the de-velopment of diet-induced obesity in FVB/N mice. Endocrinology 2008; 149:1121-1128. (Pubitemid 351397951)
49. Sahu A, Metlakunta AS: Hypothalamic phosphatidylinositol 3-kinase-phosphodies-terase-3B cyclic AMP pathway of leptin sig-nalling is impaired following chronic central leptin infusion. J Neuroendocrinol 2005; 17: 720-726. (Pubitemid 41568098)
50. Kohno D, Nakata M, Maekawa F, Fujiwara K, Maejima Y, Kuramochi M, Shimazaki T, Okano H, Onaka T, Yada T: Leptin suppress-es ghrelin-induced activation of neuropep-tide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase-and phos-phodiesterase 3-mediated pathway. Endocrinology 2007; 148: 2251-2263. (Pubitemid 46997030)
51. Malcher-Lopes R, Di S, Marcheselli VS, Weng FJ, Stuart CT, Bazan NG, Tasker JG: Opposing crosstalk between leptin and glu-cocorticoids rapidly modulates synaptic ex-citation via endocannabinoid release. J Neu-rosci 2006; 26: 6643-6650. (Pubitemid 44318346)
52. Dallman MF, La Fleur SE, Pecoraro NC, Go-mez F, Houshyar H, Akana SF: Glucocorti-coids-food intake, abdominal obesity, and wealthy nations in 2004. Endocrinology 2004; 145:2633-2638. (Pubitemid 38686208)
53. Jo YH, Chen YJ, Chua SC Jr, Talmage DA, Role LW: Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 2005; 48:1055-1066. (Pubitemid 41814707)
54. Xu Y, Hill JW, Fukuda M, Gautron L, Sohn JW, Kim KW, Lee CE, Choi MJ, Lauzon DA, Dhillon H, Lowell BB, Zigman JM, Zhao JJ, Elmquist JK: PI3K signaling in the ventro-medial hypothalamic nucleus is required for normal energy homeostasis. Cell Metab 2010; 12:88-95.
55. Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A, Su K, Cheng B, Li X, Har-vey-White J, Schwartz GJ, Kunos G, Rossetti L, Buettner C: Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med 2008; 14:667-675. (Pubitemid 351809549)
56. Hill JW, Xu Y, Preitner F, Fukuda M, Cho YR, Luo J, Balthasar N, Coppari R, Cantley LC, Kahn BB, Zhao JJ, Elmquist JK: Phos-phatidylinositol 3-kinase signaling in hy-pothalamic proopiomelanocortin neurons contributes to the regulation of glucose ho-meostasis. Endocrinology 2009; 150:4874-4882.
57. Hill JW, Williams KW, Ye C, Luo J, Balthasar N, Coppari R, Cowley MA, Cantley LC, Low-ell BB, Elmquist JK: Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J Clin Invest 2008; 118:1796-1805. (Pubitemid 351632382)
58. Plum L, Rother E, Munzberg H, Wunderlich FT, Morgan DA, Hampel B, Shanabrough M, Janoschek R, Konner AC, Alber J, Suzuki A, Krone W, Horvath TL, Rahmouni K, Bru-ning JC: Enhanced leptin-stimulated PI3K activation in the CNS promotes white adi-pose tissue transdifferentiation. Cell Metab 2007; 6:431-445. (Pubitemid 350163053)
59. Al-Qassab H, Smith MA, Irvine EE, Guiller-met-Guibert J, Claret M, Choudhury AI, Sel-man C, Piipari K, Clements M, Lingard S, Chandarana K, Bell JD, Barsh GS, Smith AJ, Batterham RL, Ashford ML, Vanhaese-broeck B, Withers DJ: Dominant role of the p110ß isoform of PI3K over p110α in energy homeostasis regulation by POMC and AgRP neurons. Cell Metab 2009; 10:343-354.
60. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M: Re-combinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999; 282:1568-1575. (Pubitemid 29504050)
61. Lin S, Thomas TC, Storlien LH, Huang XF: Development of high fat diet-induced obesi-ty and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 2000; 24:639-646. (Pubitemid 30323498)
62. Levin BE, Dunn-Meynell AA: Reduced cen-tral leptin sensitivity in rats with diet-in-duced obesity. Am J Physiol Regul Integr Comp Physiol 2002; 283:R941-R948.
63. Levin BE, Dunn-Meynell AA, Banks WA: Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol 2004; 286:R143-R150. (Pubitemid 38055903)
64. Banks WA, Farrell CL: Impaired transport of leptin across the blood-brain barrier in obe-sity is acquired and reversible. Am J Physiol Endocrinol Metab 2003; 285:E10-E15. (Pubitemid 36736356)
65. Wilsey J, Zolotukhin S, Prima V, Scarpace PJ: Central leptin gene therapy fails to over-come leptin resistance associated with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2003; 285:R1011-R1020. (Pubitemid 37296352)
66. Martin TL, Alquier T, Asakura K, Furukawa N, Preitner F, Kahn BB: Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem 2006; 281: 18933-18941. (Pubitemid 44035396)
67. Cota D, Matter EK, Woods SC, Seeley RJ: The role of hypothalamic mammalian target of rapamycin complex 1 signaling in dietinduced obesity. J Neurosci 2008; 28:7202-7208.
68. Munzberg H, Flier JS, Bjorbaek C: Region-specific leptin resistance within the hypo-thalamus of dietinduced obese mice. Endocrinology 2004; 145:4880-4889. (Pubitemid 39551104)
69. Metlakunta AR, Sahu A: Evidence suggesting impaired hypothalamic phosphati-dylinositol 3-kinase pathway of leptin signaling during the development of dietinduced obesity in mice. Front Neuro Endocrinol 2006; 27:10.
70. Bjorbaek C, Elmquist JK, Frantz JD, Shoel-son SE, Flier JS: Identification of SOCS-3 as a potential mediator of central leptin resis-tance. Mol Cell 1998; 1:619-625. (Pubitemid 128374698)
71. Mori H, Hanada R, Hanada T, Aki D, Mashi-ma R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, Yoshimura A: Socs3 defi-ciency in the brain elevates leptin sensitivity and confers resistance to dietinduced obesity. Nat Med 2004; 10:739-743. (Pubitemid 38937640)
72. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS: Enhanced leptin sensi-tivity and attenuation of dietinduced obesity in mice with haploinsufficiency of Socs3. Nat Med 2004; 10:734-738. (Pubitemid 38937639)
73. Ziotopoulou M, Mantzoros CS, Hileman SM, Flier JS: Differential expression of hypo-thalamic neuropeptides in the early phase of dietinduced obesity in mice. Am J Physiol Endocrinol Metab 2000; 279:E838-E845.
74. Sahu A, Metlakunta AR, Sahu M: Suppressor of cytokine signaling-3 interacts with the phosphatidylinositol 3-kinase pathway of leptin signaling in the hypothalamus. Pro-gram No. 60.10. 2006 Neuroscience Meeting Planner. Atlanta, Society for Neuroscience, 2006.
75. Knight ZA, Hannan KS, Greenberg ML, Friedman JM: Hyperleptinemia is required for the development of leptin resistance. PLoS ONE 2010; 5:e11376.
76. Sahu A: Resistance to the satiety action of leptin following chronic central leptin infu-sion is associated with the development of leptin resistance in neuropeptide Y neu-rones. J Neuroendocrinol 2002; 14: 796-804. (Pubitemid 35203477)
77. Sahu A: Effects of chronic central leptin in-fusion on proopiomelanocortin and neuro-tensin gene expression in the rat hypothala-mus. Neurosci Lett 2008; 440: 125-129.
78. Pal R, Sahu A: Leptin signaling in the hypo-thalamus during chronic central leptin infu-sion. Endocrinology 2003; 144: 3789-3798. (Pubitemid 37088731)